Structure via PubChem · Public domain (PubChem)
dinapsoline
Sign in to saveDinapsoline is a drug developed for the treatment of Parkinson's disease, that acts as a selective full agonist at the dopamine D1 receptor.
Chemical data
- Formula
- C16H15NO2
- Molecular weight
- 253.29 g/mol
- IUPAC name
- (1S)-15-azatetracyclo[7.7.1.02,7.013,17]heptadeca-2(7),3,5,9(17),10,12-hexaene-5,6-diol
- SMILES
- C1[C@H]2C3=C(CC4=C2C(=CC=C4)CN1)C(=C(C=C3)O)O
- InChIKey
- ZQTSNGJHMUKLOM-ZDUSSCGKSA-N
- XLogP
- 2.1
- Polar surface area
- 52.5 Ų
- H-bond donors
- 3
- H-bond acceptors
- 3
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Molecule type
- Small molecule
via ChEMBL · EBI
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 253.110279
Show 4 more facts
- isomeric SMILES
- C1[C@H]2C3=C(CC4=C2C(=CC=C4)CN1)C(=C(C=C3)O)O
- chemical formula
- C₁₆H₁₅NO₂
- canonical SMILES
- C1C2C3=C(CC4=C2C(=CC=C4)CN1)C(=C(C=C3)O)O
- Commons category
- Dinapsoline
Sources (1)
via Wikidata · CC0
~1 min read
Encyclopedic overview
1 sectionsContents
- References
Dinapsoline is a drug developed for the treatment of Parkinson's disease, that acts as a selective full agonist at the dopamine D1 receptor.
== References ==
Excerpted from Wikipedia’s “dinapsoline” article, available under the CC BY-SA 4.0 licence.